From pharmaceutical companies, and downtown traders, to online sellers, the race to get a slice of the obesity market is cutthroat.
Globally, Morgan Stanley Research made a bullish prediction, showing that the sale of obesity drugs could reach $54 billion (Sh6.7 trillion) by 2023, but this is before factoring in counterfeits sold in black markets.
